Total buying$00 buys
ANIP
ANI PHARMACEUTICALS INC
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$633k3 sells
Net open-market−$633kBuying minus selling
Active insiders3Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 16, 2026
Open-market transaction mix · 3 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 1 | 0 | $0 | $208k | -$208k |
| Oct 2026 | 0 | 2 | 0 | $0 | $425k | -$425k |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (2)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- LN-$388.2k
- CP-$208.1k
- CM-$36.8k
ANIP transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
ANIPANI PHARMACEUTICALS INC | Lalwani NikhilPRES · CEO | S · sale10b5-1 detectedSEC filing ↗ | -$388kView disclosure → | |
ANIPANI PHARMACEUTICALS INC | Cook MeredithSV · GC · SEC | S · sale10b5-1 detectedSEC filing ↗ | -$36.7kView disclosure → | |
ANIPANI PHARMACEUTICALS INC | Carey Stephen P.SVP · CFO | S · sale10b5-1 detectedSEC filing ↗ | -$208kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Recent filing activity
Most recent 3 transactions on this page · color = transaction codeFiling detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period3transactionstxns
- S · Open-market sells · dominant3 · 100%
Activity by reported role
A joint filing can contribute to multiple rolesChief executive officer1
Chief financial officer1
GC1
PRES1
SEC1
SV1
SVP1
Reported Holdings After
Separated by insider, security, and ownership type
Carey Stephen P.Common Stock · Direct
168,993Sep 29, 2026
Cook MeredithCommon Stock · Direct
73,424Oct 13, 2026
Lalwani NikhilCommon Stock · Direct
333,689Oct 15, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
ANI PHARMACEUTICALS INC Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at ANI PHARMACEUTICALS INC?
Lalwani Nikhil, Cook Meredith, CAREY STEPHEN P..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Lalwani Nikhil reported a sale on Oct 15, 2026 valued at $388k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $633,051.00. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.